ROCHESTER, N.Y.--(BUSINESS WIRE)--Lucid, Inc. today announced that it has connected the first users to its proprietary VivaNet® system, a telemedicine network designed to allow dermatologists and pathologists to share high-resolution images of suspicious skin lesions taken with the Company’s VivaScope® confocal imagers. The first users were connected in the New York City area. The Company’s VivaScope cellular imaging technology, which comprises the VivaScope System, received FDA 510(k) regulatory clearance on September 17, 2008.
